<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:54:38Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8078086" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8078086</identifier>
        <datestamp>2021-04-28</datestamp>
        <setSpec>pheelsevier</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3-mathml3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Comput Biol Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Comput Biol Med</journal-id>
              <journal-title-group>
                <journal-title>Computers in Biology and Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0010-4825</issn>
              <issn pub-type="epub">1879-0534</issn>
              <publisher>
                <publisher-name>Elsevier Ltd.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8078086</article-id>
              <article-id pub-id-type="pmcid">PMC8078086</article-id>
              <article-id pub-id-type="pmc-uid">8078086</article-id>
              <article-id pub-id-type="pmid">33930762</article-id>
              <article-id pub-id-type="pii">S0010-4825(21)00216-X</article-id>
              <article-id pub-id-type="doi">10.1016/j.compbiomed.2021.104422</article-id>
              <article-id pub-id-type="publisher-id">104422</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Microscopic dynamics modeling unravels the role of asymptomatic virus carriers in SARS-CoV-2 epidemics at the interplay between biological and social factors</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au1">
                  <name>
                    <surname>Tadić</surname>
                    <given-names>Bosiljka</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">a</xref>
                  <xref rid="aff3" ref-type="aff">c</xref>
                  <xref rid="cor1" ref-type="corresp">∗</xref>
                </contrib>
                <contrib contrib-type="author" id="au2">
                  <name>
                    <surname>Melnik</surname>
                    <given-names>Roderick</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">b</xref>
                  <xref rid="aff4" ref-type="aff">d</xref>
                </contrib>
                <aff id="aff1"><label>a</label>Department of Theoretical Physics, Jožef Stefan Institute, Jamova 39, Ljubljana, Slovenia</aff>
                <aff id="aff2"><label>b</label>MS2Discovery Interdisciplinary Research Institute, M2NeT Laboratory and Department of Mathematics, Wilfrid Laurier University, Waterloo, ON, Canada</aff>
                <aff id="aff3"><label>c</label>Complexity Science Hub, Josefstaedter Strasse 39, Vienna, Austria</aff>
                <aff id="aff4"><label>d</label>BCAM - Basque Center for Applied Mathematics, Alameda de Mazarredo 14, E-48009, Bilbao, Spain</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>∗</label>Corresponding author. Department of Theoretical Physics, Jožef Stefan Institute, Jamova 39, Ljubljana, Slovenia.</corresp>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>24</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <volume>133</volume>
              <fpage>104422</fpage>
              <lpage>104422</lpage>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>16</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>17</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Elsevier Ltd. All rights reserved.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Elsevier Ltd</copyright-holder>
                <license>
                  <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
                </license>
              </permissions>
              <abstract id="abs0010">
                <p>The recent experience of SARS-CoV-2 epidemics spreading revealed the importance of passive forms of infection transmissions. Apart from the virus survival outside the host, the latent infection transmissions caused by asymptomatic and presymptomatic hosts represent major challenges for controlling the epidemics. In this regard, social mixing and various biological factors play their subtle, but often critical, role. For example, a life-threatening condition may result in the infection contracted from an asymptomatic virus carrier. Here, we use a new recently developed microscopic agent-based modelling framework to shed light on the role of asymptomatic hosts and unravel the interplay between the biological and social factors of these nonlinear stochastic processes at high temporal resolution. The model accounts for each human actor's susceptibility and the virus survival time, as well as traceability along the infection path. These properties enable an efficient dissection of the infection events caused by asymptomatic carriers from those which involve symptomatic hosts before they develop symptoms and become removed to a controlled environment. Consequently, we assess how their relative proportions in the overall infection curve vary with changing model parameters. Our results reveal that these proportions largely depend on biological factors in the process, specifically, the virus transmissibility and the critical threshold for developing symptoms, which can be affected by the virus pathogenicity. Meanwhile, social participation activity is crucial for the overall infection level, further modulated by the virus transmissibility.</p>
              </abstract>
              <kwd-group id="kwrds0010">
                <title>Keywords</title>
                <kwd>Agent-based modelling of epidemics</kwd>
                <kwd>Asymptomatic hosts of SARS-CoV-2</kwd>
                <kwd>Evolving bipartite graphs</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1">
              <label>1</label>
              <title>Introduction</title>
              <p id="p0025">Epidemics spreading of new coronavirus in population is a collective social phenomenon. It arises from individual actors’ behaviour that can get infected and spread the infectious agents via multiplexity of contacts. In this regards, the human participation activity conditioned by daily mobility patterns has been recognised as a primary driving force for the epidemics spreading [<xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>]. Contrary to many social processes, the epidemic spreading has a vital biological component, which is prominent at the elementary interactions scale [<xref rid="bib4" ref-type="bibr">4</xref>,<xref rid="bib5" ref-type="bibr">5</xref>]. In this respect, the recent developments with the SARS-CoV-2 epidemics have revealed several new features that were not previously recognised in virus spreading, see recent update in Ref. [<xref rid="bib6" ref-type="bibr">6</xref>]. These are sizeable effects of the passive modes of the infection transmission [<xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>], which can be related to the virus biology and strongly individual susceptibility of the human hosts to this particular virus [<xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>]. Specifically, these latent infection transmissions rely on the virus long survival time outside the human host [<xref rid="bib14" ref-type="bibr">14</xref>,<xref rid="bib17" ref-type="bibr">17</xref>], which enables an indirect transmission to a new host. On the other hand, a considerable amount of asymptomatic hosts can remain unidentified [<xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>]. Recent empirical studies of COVID-19 epidemics reveal the silent transmissions occurring in different social or familiar circles [<xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>]. Efforts are made to evaluate the contributions of presymptomatic and asymptomatic cases and their implications to control the epidemics [<xref rid="bib25" ref-type="bibr">25</xref>,<xref rid="bib26" ref-type="bibr">26</xref>], in particular, by combining mathematical modelling with available biomedical data for a given population. For example, in an outstanding study [<xref rid="bib26" ref-type="bibr">26</xref>], the authors take into account data on the seroprevalence for SARS-CoV-2 antibodies in populations on nine different locations in conjunction with compartmental epidemics modelling to project “the temporal evolution and credible intervals of the effective reproduction number and the symptomatic, asymptomatic and recovered populations”. Noteworthy, these results revealed a symptomatic fraction that remains bellow 20% in all locations. Here, we address these issues using the microscopic agent-based modelling to reveal how different outcomes at the population level can emerge in the interplay of high-resolution social dynamics and relevant biological factors.</p>
              <p id="p0030">Since the very beginning of the SARS-CoV-2 epidemics, it has been revealed that a wide spectrum of symptoms may occur, from very mild or none, on one side, to severe symptoms and life-threatening pneumonia requiring ICU treatment and possible fatal outcome [<xref rid="bib14" ref-type="bibr">14</xref>]. Apart from potential virus mutations over time, e.g., changed transmissibility and pathogenicity [<xref rid="bib11" ref-type="bibr">11</xref>,<xref rid="bib27" ref-type="bibr">27</xref>,<xref rid="bib28" ref-type="bibr">28</xref>], the observed individual susceptibility of human actors to the virus may range from a specific genetic origin to diverse factors related to the individual's health condition [<xref rid="bib13" ref-type="bibr">13</xref>,<xref rid="bib29" ref-type="bibr">29</xref>,<xref rid="bib30" ref-type="bibr">30</xref>]. The symptoms develop over a short period between 2 and 7 days. Meanwhile, the asymptomatic cases spontaneously recover within a period of one to two weeks, changing infectiousness over time [<xref rid="bib24" ref-type="bibr">24</xref>,<xref rid="bib31" ref-type="bibr">31</xref>]. The evidence of the temporal variation of infectiousness before and after the symptoms as well as in asymptomatic carriers are subject of investigations and debated among researchers [<xref rid="bib32" ref-type="bibr">32</xref>,<xref rid="bib33" ref-type="bibr">33</xref>]. Even though their viral load varies differently in time [<xref rid="bib32" ref-type="bibr">32</xref>,<xref rid="bib34" ref-type="bibr">34</xref>], both symptomatic and asymptomatic hosts are the virus carries and can spread the infection, cf. <xref rid="fig1" ref-type="fig">Fig. 1</xref>
. Specifically, the circulating viruses produced by asymptomatic hosts can infect a susceptible individual, who, depending on the susceptibility, may or may not develop symptoms. Similarly, the viruses produced by presymptomatic carriers can lead to asymptomatic as well as symptomatic cases. Moreover, some measurements suggest that the viral contents are proportional to the severity of symptoms, and can vary over the infectious time [<xref rid="bib34" ref-type="bibr">34</xref>]. Early estimates were that the proportion of asymptomatic cases could be as large as 80% of all infected [<xref rid="bib14" ref-type="bibr">14</xref>]. A recent meta-analysis of the available data suggests a wide variation in the estimates from 20% up to 60% of asymptomatic carriers [<xref rid="bib20" ref-type="bibr">20</xref>,<xref rid="bib21" ref-type="bibr">21</xref>].<fig id="fig1"><label>Fig. 1</label><caption><p>Schematic view of the processes: new susceptible individuals become exposed to active viruses. An infected individual is “asymptomatic”, if its susceptibility is low <inline-formula><mml:math id="M1" altimg="si2.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&lt;</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, or “presymptomatic” if its <inline-formula><mml:math id="M2" altimg="si3.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">≥</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and develops symptoms over time; subsequently, it becomes “quarantined” or “hospitalised” and thus removed to a controlled environment. Whereas, “asymptomatic” carriers over time become “spontaneously recovered”. The active circulating viruses consist of a group produced “by asymptomatic” and “by presymptomatic” hosts. Thus, they can infect either the “asymptomatic” or “presymptomatic” group, depending on the agent's susceptibility. Groups shown in the right rectangle do not contribute to the studied latent transmissions.</p></caption><alt-text id="alttext0015">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p>
              <p id="p0035">Given the occurrence of a sizable amount of asymptomatic virus carries, it is challenging to estimate the right parameters and predictions of the epidemics from the immediate data analysis [<xref rid="bib26" ref-type="bibr">26</xref>,<xref rid="bib35" ref-type="bibr">35</xref>,<xref rid="bib36" ref-type="bibr">36</xref>]. Thus, it constitutes a considerable problem for efficient combat with the virus spreading [<xref rid="bib19" ref-type="bibr">19</xref>,<xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>]. The problem is increasingly more scientifically interesting in the third-wave epidemics because the virus circulates among a large fraction of the population. Hence, a better understanding of the factors that determine the proportion of the asymptomatic virus carries in a given social environment, and their impact on the overall infection growth is vital for managing the disease outbreak. In this work, we tackle these problems using the microscopic dynamics approach within the agent-based modelling framework developed in Ref. [<xref rid="bib1" ref-type="bibr">1</xref>].</p>
              <p id="p0040">Complementary to the standard mean-field models with continuous-time dynamics of interdependent equations for groups [<xref rid="bib40" ref-type="bibr">40</xref>,<xref rid="bib41" ref-type="bibr">41</xref>], the microscopic agent-based modelling of SARS-CoV-2 epidemics gains an increasing attention [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>, <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>]. As remarkable examples, we mention the modelling frameworks that were developed to simulate the epidemic outcomes by including accurate patterns of mobility at a particular geographic location [<xref rid="bib44" ref-type="bibr">44</xref>] or statistical data of a given population [<xref rid="bib47" ref-type="bibr">47</xref>]. This modelling approach provides us with intrinsic mechanisms of the epidemic processes, and the information on how it develops from the elementary-interaction level to the global-scale outcome. Moreover, it allows for considering individual features of the actors, their mobility and location of the interactions and participation in coupled stochastic processes [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>, <xref rid="bib46" ref-type="bibr">[46]</xref>] and intra-host viral dynamics [<xref rid="bib47" ref-type="bibr">47</xref>]. We have recently developed an agent-based model for the latent infection transmissions [<xref rid="bib1" ref-type="bibr">1</xref>], where the human actors possess individual susceptibility to the virus. It thus allows us to differentiate between highly susceptible individuals, who can develop symptoms from those who are less susceptible and may become asymptomatically infected. The new host's susceptibility accordingly modulates the probability of getting infected and the probability of that host to produce a new generation of viruses. Moreover, the model enables us to consider a finite survival time of the virus outside the host and different exposure times of each human actor. The process is visualised as a growing bipartite graphs, see <xref rid="fig2" ref-type="fig">Fig. 2</xref>
, with host nodes who are producing the virus nodes (infected spots) during their infectious time and proportionally to the degree of infectiousness. A more detailed description of the model is given in the next section, see also [<xref rid="bib1" ref-type="bibr">1</xref>] for further details. This graphic representation of the process enables us to identify an infection path leading to each case. Therefore, in this modelling approach, each infection event where an actor encounters the virus is marked by the new host's features and the host that produces the active virus.<fig id="fig2"><label>Fig. 2</label><caption><p>The close-up bipartite network of Host (large, blue) and Virus (small, white) nodes. The directed blue edges connect the Host with the viruses that it produced. Infection paths along the directed edges between successive Hosts via Virus nodes are shown in red.</p></caption><alt-text id="alttext0020">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p>
              <p id="p0045">In this work, we extend the developed modelling framework for latent infections such that we keep the information about the preceding host's susceptibility when the virus is transmitted to a new host. In this way, each infection case can be distinguished as either coming from a sensitive, i.e., potentially symptomatic case before it gets hospitalised or quarantined, or otherwise from a low-susceptibility host being asymptomatic. The <italic>threshold susceptibility</italic>
<inline-formula><mml:math id="M3" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, which distinguishes the highly susceptible agents from those that are potentially asymptomatic, is a varying parameter in our model. The values of this parameter depend on the health and genetic factors of a given population and on the pathogenicity of the virus in question, possibly assessable from some empirical data [<xref rid="bib13" ref-type="bibr">13</xref>,<xref rid="bib18" ref-type="bibr">18</xref>,<xref rid="bib19" ref-type="bibr">19</xref>,<xref rid="bib21" ref-type="bibr">21</xref>]. We note that these stochastic processes involving symptomatic and asymptomatic hosts are strongly entangled at the level of interactions between the agents and viruses as the most elementary constituents of the process, cf. <xref rid="fig1" ref-type="fig">Fig. 1</xref>. Therefore, they can be suitably differentiated only at the microscopic interaction scale within individual-based modelling. Precisely, by tracing every infection event, we can differentiate the virus original host and, thus, determine its contribution to the growth of the infectious curve over time. With the extensive simulations, we demonstrate how the asymptomatic host's contribution to the infection growth varies with the social participation activity and the biological factors that determine the threshold susceptibility and transmission rate. Our simulations confirm that the overall infection level critically depends on social participation activity. Meanwhile, the biological factors are primarily responsible for the respective proportions of the asymptomatic and presymptomatic hosts in the overall infection curve.</p>
            </sec>
            <sec id="sec2">
              <label>2</label>
              <title>Latent infection transmissions: model details</title>
              <p id="p0050">We adopt the model for latent infection transmissions developed in Ref. [<xref rid="bib1" ref-type="bibr">1</xref>], specifically, introducing the differentiation between an asymptomatic infected case from those who can develop symptoms, as schematically shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>. As in the original work [<xref rid="bib1" ref-type="bibr">1</xref>], the visualisation of the process by an evolving bipartite graph enables us to identify the infection path leading to each agent. It consists of infected individuals (Host nodes), who can produce viral spots (Virus nodes) during their infectious time, cf. <xref rid="fig2" ref-type="fig">Fig. 2</xref>. The <italic>social participation</italic> activity drives the dynamics; as a good proxy, we use an empirical time series <inline-formula><mml:math id="M4" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> inferred from social networks [<xref rid="bib48" ref-type="bibr">48</xref>]. In analogy to the time series of the human mobility within cities [<xref rid="bib44" ref-type="bibr">44</xref>,<xref rid="bib49" ref-type="bibr">49</xref>], this time series represents a cumulative activity of an open social group in an area with circulating viruses. Thus, it does not assume any prior relationships among participants (see also the Discussion section).</p>
              <p id="p0055">Features that influence the dynamics are several individual characteristics of the human actors <inline-formula><mml:math id="M5" altimg="si5.svg"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mo>…</mml:mo><mml:mo stretchy="true">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and viruses <inline-formula><mml:math id="M6" altimg="si6.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mo>…</mml:mo><mml:mo stretchy="true">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> summarised as follows<disp-formula id="fd1"><label>(1)</label><mml:math id="M7" altimg="si7.svg" alttext="Equation 1."><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>;</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>r</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo>;</mml:mo><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow><mml:mo>;</mml:mo><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>;</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo>;</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>;</mml:mo><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow><mml:mspace width="0.25em"/><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>
</p>
              <p id="p0060">Specifically, apart from a unique identity, <italic>i</italic>, each human actor has its individual <italic>susceptibility</italic> to the virus, <inline-formula><mml:math id="M8" altimg="si8.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, which critically determines its role in the process; in particular, it modifies the agent's likelihood of infection in contact with the virus and also its productivity of new viruses after infection has occurred, as explained below. For each created agent, it is taken from a uniform random distribution in the range <inline-formula><mml:math id="M9" altimg="si9.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">∈</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mn>0,1</mml:mn><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Furthermore, each agent has a characteristic exposition to the viruses specified by its <italic>exposure time</italic>
<inline-formula><mml:math id="M10" altimg="si10.svg"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> measured in hours; we take a uniform random number <inline-formula><mml:math id="M11" altimg="si11.svg"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak" linebreakstyle="after">∈</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, where <inline-formula><mml:math id="M12" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>24</mml:mn></mml:mrow></mml:math></inline-formula> hours. As mentioned in the Introduction, when a highly susceptible agent <inline-formula><mml:math id="M13" altimg="si3.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">≥</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is infected, it can develop symptoms over a certain number of days, <inline-formula><mml:math id="M14" altimg="si13.svg"><mml:mrow><mml:msubsup><mml:mi>r</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak" linebreakstyle="after">∈</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mn>2,7</mml:mn><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, characteristic to that agent; consequently, it stops contributing to the latent transmissions by moving to a controlled environment (hospital or quarantine) [<xref rid="bib1" ref-type="bibr">1</xref>]. Meanwhile, individuals with the susceptibility below a threshold <inline-formula><mml:math id="M15" altimg="si2.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&lt;</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> would not develop symptoms by contracting the viruses; they will stay asymptomatically infected and eventually will spontaneously recover after <inline-formula><mml:math id="M16" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> days and removed from the process. In the model, <inline-formula><mml:math id="M17" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is a parameter equal to all asymptomatic agents. The infectious time of each host is counted from the moment the infection occurred. Both the asymptomatic and presymptomatic hosts can produce viruses throughout their infectious time, although in different amounts [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib7" ref-type="bibr">7</xref>]. In the model, the amount of viruses is proportional to the host's susceptibility, which remains unchanged throughout its infectious time [<xref rid="bib1" ref-type="bibr">1</xref>]. On the other hand, each virus node is characterised by a unique identity <italic>j</italic>, survival time <inline-formula><mml:math id="M18" altimg="si15.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and its generation <inline-formula><mml:math id="M19" altimg="si16.svg"><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> (the number of the hosts along the infection path) [<xref rid="bib1" ref-type="bibr">1</xref>]. Besides, for this work, each Virus node has a new property, <inline-formula><mml:math id="M20" altimg="si17.svg"><mml:mrow><mml:msubsup><mml:mi>O</mml:mi><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>, which is given by the host's susceptibility that produced that virus. At present, we do not consider different variants of the virus; thus, a unique survival time <inline-formula><mml:math id="M21" altimg="si15.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> applies as a parameter. Here, we also do not consider potential mutations along the infection path. In Ref. [<xref rid="bib1" ref-type="bibr">1</xref>], by keeping track of the number of hops of the virus (virus generation) since the original infection case, its potential mutations can eventually moderate the transmission rate. For the present work, we keep the mutation factor fixed, i.e., <inline-formula><mml:math id="M22" altimg="si18.svg"><mml:mrow><mml:mi>g</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. Other values can also be analysed with the developed framework once reliable data on mutation patterns become available [<xref rid="bib28" ref-type="bibr">28</xref>]. During the process, each virus's state changes from “active” when its host produces the virus to “expire” once its survival time exceeds the value <inline-formula><mml:math id="M23" altimg="si15.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. Similarly, the state of each human actor changes from “susceptible” to “exposed (for active viruses)” to “active carrier” when infected. Further differentiation is caused by its susceptibility corresponds to a transition path in <xref rid="fig1" ref-type="fig">Fig. 1</xref> towards either “spontaneously recovered” or “hospitalised or quarantined”, see section III for simulation details.</p>
              <p id="p0065">As in the original model, in each event the basic transmission rate <inline-formula><mml:math id="M24" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> is modulated by the individual susceptibility of the agent <italic>i</italic> encountering the virus at the moment <italic>t</italic>, see Eq. <xref rid="fd2" ref-type="disp-formula">(2)</xref>. In addition, the probability <inline-formula><mml:math id="M25" altimg="si20.svg"><mml:mrow><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> also varies in time due to the fluctuations in the global viral load <inline-formula><mml:math id="M26" altimg="si21.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Specifically,<disp-formula id="fd2"><label>(2)</label><mml:math id="M27" altimg="si22.svg" alttext="Equation 2."><mml:mrow><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mtext>Φ</mml:mtext><mml:mi>t</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>g</mml:mi><mml:mspace width="0.25em"/><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where the global feedback factor <inline-formula><mml:math id="M28" altimg="si23.svg"><mml:mrow><mml:msub><mml:mtext>Φ</mml:mtext><mml:mi>t</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">≡</mml:mo><mml:mi>d</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">/</mml:mo><mml:mi>d</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> follows the temporal fluctuations of the viral load with respect to the current number of active carriers <inline-formula><mml:math id="M29" altimg="si24.svg"><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Note that the upper limit of the virus production rate at time <italic>t</italic> corresponds to a hypothetical situation where each active carrier has the maximum susceptibility <inline-formula><mml:math id="M30" altimg="si25.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> producing a new virus at every time step. Hence, the temporal feedback in the fluctuating transmission rate of Eq. <xref rid="fd2" ref-type="disp-formula">(2)</xref> accounts for the actual <italic>heterogeneity</italic> of the virus carriers. The potential origin of the hosts' heterogeneity mentioned in the Discussion can further modulate the transition rate.</p>
            </sec>
            <sec id="sec3">
              <label>3</label>
              <title>Microscopic dynamics and sampled quantities</title>
              <p id="p0070">As shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>, the process is driven by the empirical time series <inline-formula><mml:math id="M31" altimg="si26.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy="true">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> representing the temporal fluctuations of the social activity level. Thus, this time series's resolution and length define the time step and duration of simulations, respectively. Moreover, its intensity determines the number of agents created during the simulations as <inline-formula><mml:math id="M32" altimg="si27.svg"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msubsup><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mi>t</mml:mi></mml:msubsup><mml:msub><mml:mi>s</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:msub></mml:mrow></mml:math></inline-formula>. Specifically, at an <italic>hourly resolution</italic> it brings <inline-formula><mml:math id="M33" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> new susceptible agents, which become exposed to active viruses. Note that the viruses can survive outside the hosts, such that the currently active viruses are those produced by all active carriers (asymptomatic as well as presymptomatic) within the past <inline-formula><mml:math id="M34" altimg="si28.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula> hours, corresponding to the considered virus survival time. Each agent remains exposed for a period corresponding to its exposure time <inline-formula><mml:math id="M35" altimg="si10.svg"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, during which it can get infected with the probability given by Eq. <xref rid="fd2" ref-type="disp-formula">(2)</xref>. If infected, the agent is removed from the exposed agent's list and appears in one of the infected agent's groups, i.e., asymptomatic (if its susceptibility is below the threshold <inline-formula><mml:math id="M36" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), or presymptomatic, if <inline-formula><mml:math id="M37" altimg="si3.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">≥</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. During their respective infectious times, the agents in both groups produce new viruses with a pace that is modulated by the agent's susceptibility. After developing symptoms within an individual time interval of <inline-formula><mml:math id="M38" altimg="si13.svg"><mml:mrow><mml:msubsup><mml:mi>r</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak" linebreakstyle="after">∈</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mn>2,7</mml:mn><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> days, each symptomatic agent is hospitalised or quarantined and removed from the process. Whereas, each asymptomatic agent stays in the process until its spontaneous recovery after <inline-formula><mml:math id="M39" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> days (equal to all agents). A detailed program flow is given in the Appendix.</p>
              <p id="p0075">As explained above, in the model, we keep information about the origin of each virus. Hence, in each new infection event, the number of infected <inline-formula><mml:math id="M40" altimg="si29.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> increases by one if the virus originates from an asymptomatic host, and, in the case of a presymptomatic host, <inline-formula><mml:math id="M41" altimg="si30.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is increased. In each case the total number of infected agents per time step, <inline-formula><mml:math id="M42" altimg="si31.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">+</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> increases, however, the relative proportions of <inline-formula><mml:math id="M43" altimg="si29.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M44" altimg="si30.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> can vary, depending on several parameters, as we show in the following. As it is schematically indicated in <xref rid="fig1" ref-type="fig">Fig. 1</xref>, these two processes are strongly interlinked at the microscopic scale. Particularly, the infection <italic>by presymptomatic</italic> hosts can end up as an asymptomatic as well as a presymptomatic case, depending on the susceptibility of the new exposed agent. Similarly, an infection <italic>by asymptomatic</italic> hosts can result in either an asymptomatic or symptomatic case; but each symptomatic case may eventually end up in the intensive care unit with an uncertain outcome, depending on its susceptibility [<xref rid="bib13" ref-type="bibr">13</xref>,<xref rid="bib50" ref-type="bibr">50</xref>]. Given the difficulty in detecting asymptomatic virus carriers in real life, understanding the intrinsic mechanisms along this potential line of events is of great importance.</p>
              <p id="p0080">This microscopic modelling framework allows us to keep full control of the process, which results in different time-varying quantities, as shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref>
. Specifically, for the time period spanning eight weeks and resolution of 1 h, at each time step <inline-formula><mml:math id="M45" altimg="si37.svg"><mml:mrow><mml:mi>i</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1,2</mml:mn><mml:mo>⋯</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> new agents are imported, and their individual properties <inline-formula><mml:math id="M46" altimg="si8.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M47" altimg="si10.svg"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> are fixed. Then at each time step, we determine the number of currently exposed agents <inline-formula><mml:math id="M48" altimg="si32.svg"><mml:mrow><mml:msub><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, the number of agents infected from viruses by asymptomatic hosts, <inline-formula><mml:math id="M49" altimg="si29.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, and by-presymptomatic hosts, <inline-formula><mml:math id="M50" altimg="si30.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>. By respecting the individual hospitalisation time for each presymptomatic host and spontaneous recovery time for all asymptomatic ones, as well as the virus survival time, we compute the number of active carriers <inline-formula><mml:math id="M51" altimg="si24.svg"><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and active viruses <inline-formula><mml:math id="M52" altimg="si21.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Having these quantities at hand, we determine the actual transmission rate <inline-formula><mml:math id="M53" altimg="si20.svg"><mml:mrow><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> via eq. <xref rid="fd2" ref-type="disp-formula">(2)</xref>, at each infection event. Its temporal profile can express the impact of the basic transmission rate <inline-formula><mml:math id="M54" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, as shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref> bottom panel, as well as a potential self-tuning during the process, e.g., by altered social activity or virus mutations [<xref rid="bib1" ref-type="bibr">1</xref>].<fig id="fig3"><label>Fig. 3</label><caption><p>Temporal fluctuations of the number of agents: (a) 1–socially active or susceptible <inline-formula><mml:math id="M55" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, 2–exposed agents <inline-formula><mml:math id="M56" altimg="si32.svg"><mml:mrow><mml:msub><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, 3–infected by asymptomatic <inline-formula><mml:math id="M57" altimg="si29.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and 4–by presymptomatic <inline-formula><mml:math id="M58" altimg="si30.svg"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> hosts. (b) H–The number of active carriers <inline-formula><mml:math id="M59" altimg="si24.svg"><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and V–active viruses <inline-formula><mml:math id="M60" altimg="si21.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. (c) The corresponding total number of infected agents <inline-formula><mml:math id="M61" altimg="si33.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> (infectious curve), the proportions of infected by asymptomatic and by presymptomatic hosts, and the total number of spontaneously recovered, and hospitalised and quarantined over time. In the simulations, we fixed <inline-formula><mml:math id="M62" altimg="si28.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula> h, maximum exposure time <inline-formula><mml:math id="M63" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>24</mml:mn></mml:mrow></mml:math></inline-formula> h, the spontaneous recovery time <inline-formula><mml:math id="M64" altimg="si34.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:math></inline-formula> days, and the threshold value <inline-formula><mml:math id="M65" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M66" altimg="si36.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.23</mml:mn></mml:mrow></mml:math></inline-formula>. (d) The actual values of the transmission rate <inline-formula><mml:math id="M67" altimg="si20.svg"><mml:mrow><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> occurring in the sequence of infection events within the corresponding time frame, for two values of the basic rate <inline-formula><mml:math id="M68" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> indicated in the legend. The number of agents created is 9040; among them, 5823 became infected and produced 1307183 virus nodes during the simulation.</p></caption><alt-text id="alttext0025">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig></p>
              <p id="p0085">In the following, we simulate the infection process by varying the relevant parameters, i.e., the transmission rate <inline-formula><mml:math id="M69" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, the threshold susceptibility <inline-formula><mml:math id="M70" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and the recovery time <inline-formula><mml:math id="M71" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> of agents and the social activity level. These simulations enable us to assess their impact on the proportion of infections caused by asymptomatic and presymptomatic virus carriers.</p>
            </sec>
            <sec id="sec4">
              <label>4</label>
              <title>Proportion of cases infected by asymptomatic carriers for varied parameters</title>
              <p id="p0090">As shown above, the cases <italic>infected by asymptomatic</italic> hosts can be differentiated at the microscopic dynamics scale from the cases <italic>infected by presymptomatic</italic> hosts. Consequently, their relative contributions to the growth of the infectious curve can be systematically estimated. Here, we focus on how these proportions vary in time (always starting from one symptomatic infected case), and how they depend on relevant parameters. Firstly, for a given social activity time series and fixed maximum exposure times of agents <inline-formula><mml:math id="M72" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>24</mml:mn></mml:mrow></mml:math></inline-formula> hours, we consider different values of the threshold susceptibility <inline-formula><mml:math id="M73" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and the recovery time of asymptomatic hosts <inline-formula><mml:math id="M74" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. Specifically, for the same driving time series <inline-formula><mml:math id="M75" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> as in <xref rid="fig3" ref-type="fig">Fig. 3</xref>, we show in <xref rid="fig4" ref-type="fig">Fig. 4</xref>
that the relative proportions of the cases infected by asymptomatic and by presymptomatic hosts strongly depend on the recognised threshold susceptibility. Meanwhile, the total number of infected remains statistically similar, being chiefly conditioned by the social participation activity. For example, for the threshold <inline-formula><mml:math id="M76" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula>, corresponding to 80% asymptomatic cases, the fraction of infected by asymptomatic carriers levels up at 94% of all cases, whereas the remaining 6% cases are infected by presymptomatic virus carriers. The corresponding temporal evolution of these fractions is shown in the top-right panel of <xref rid="fig5" ref-type="fig">Fig. 5</xref>
, starting from a single symptomatic case. On the other hand, by assuming that asymptomatic infections comprise of 40% of all cases, i.e., the threshold susceptibility <inline-formula><mml:math id="M77" altimg="si38.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></inline-formula>, the total number of infected by presymptomatic carriers is initially higher, but the events attributed to infections by asymptomatic carriers win at later times. Eventually, for even lower values of the threshold, the number of infected by asymptomatic hosts remain below the number of infected by presymptomatic. The exact proportions evolve over time, as shown in <xref rid="fig5" ref-type="fig">Fig. 5</xref>, depending not only on the threshold value but also on the infectious time <inline-formula><mml:math id="M78" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> of the participants. The outcomes (averaged over the last 682 evolution steps) are shown in the bottom panel of <xref rid="fig4" ref-type="fig">Fig. 4</xref> for the whole range of threshold values and two infectious periods of the asymptomatic carriers, <inline-formula><mml:math id="M79" altimg="si39.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula> 7 and 14 days, respectively.<fig id="fig4"><label>Fig. 4</label><caption><p>Top panel: Infection curve <inline-formula><mml:math id="M80" altimg="si40.svg"><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> versus time (thin full lines) and the respective proportions of the cumulative number of infected by asymptomatic hosts (thick full lines) and by presymptomatic hosts (broken lines) for the threshold susceptibility <inline-formula><mml:math id="M81" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M82" altimg="si38.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></inline-formula>. The recovery time of asymptomatic cases is <inline-formula><mml:math id="M83" altimg="si39.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula>14 days, other parameters are fixed (<inline-formula><mml:math id="M84" altimg="si41.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula>0.23, <inline-formula><mml:math id="M85" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>24</mml:mn></mml:mrow></mml:math></inline-formula> h, <inline-formula><mml:math id="M86" altimg="si42.svg"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula>4 h). Bottom panel: For varied threshold susceptibility <inline-formula><mml:math id="M87" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, the emergent proportions of infected by asymptomatic (open symbols) and by presymptomatic (filled symbols) plotted against <inline-formula><mml:math id="M88" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>; two sets of curves correspond to <inline-formula><mml:math id="M89" altimg="si39.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula>14 and 7 days, as indicated in the legend.</p></caption><alt-text id="alttext0030">Fig. 4</alt-text><graphic xlink:href="gr4_lrg"/></fig><fig id="fig5"><label>Fig. 5</label><caption><p>Time evolution of the proportions of the infections by the asymptomatic (A) and presymptomatic (S) cases for varied threshold susceptibility <inline-formula><mml:math id="M90" altimg="si43.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula> 0.8, 0.6, 0.4, and 0.2 (top to bottom panels). The spontaneous recovery time of asymptomatic cases is <inline-formula><mml:math id="M91" altimg="si39.svg"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo></mml:mrow></mml:math></inline-formula>7 days (left column) and 14 days (right column).</p></caption><alt-text id="alttext0035">Fig. 5</alt-text><graphic xlink:href="gr5_lrg"/></fig></p>
              <p id="p0095">Next, we examine how these proportions depend on the social participation level and the basic transmission rate <inline-formula><mml:math id="M92" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. For this purpose, we extend the duration of the process. We use the same driving signal for the first eight weeks and then the signal with the reduced intensity but the same fractal structure for the following eight weeks, as shown in the top panel of <xref rid="fig6" ref-type="fig">Fig. 6</xref>
. The simulation results for the infectious curves are shown in two bottom panels in <xref rid="fig6" ref-type="fig">Fig. 6</xref>. As this figure shows, the reduced social participation activity leads to the gradually slower growth of the total infection curve, in agreement with the findings in Ref. [<xref rid="bib1" ref-type="bibr">1</xref>] supporting the idea of social lock-down measures. Here, we are interested in how these variations in the social activity level combined with the transmission rate can affect the relative proportions of the infected by asymptomatic and by presymptomatic carriers. Specifically, we consider two cases of the threshold susceptibility, <inline-formula><mml:math id="M93" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M94" altimg="si44.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula>, and two basic transition rates; the value <inline-formula><mml:math id="M95" altimg="si36.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.23</mml:mn></mml:mrow></mml:math></inline-formula>, according to early estimates of the average rate [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib42" ref-type="bibr">42</xref>], and 70% increased transmission rate <inline-formula><mml:math id="M96" altimg="si45.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.39</mml:mn></mml:mrow></mml:math></inline-formula>, suggested by news regarding recent mutations; the results are displayed in <xref rid="fig6" ref-type="fig">Fig. 6</xref>. These results reveal that, for a low basic transmission rate, even though the social activity level strongly influences the total number of cases, the <italic>relative proportions</italic> of these cases infected by asymptomatic and by presymptomatic carriers remain virtually unaffected. However, the increased basic transmission rate increases both the total number of infected and alters the proportions of the infected by asymptomatic and by presymptomatic carriers. Moreover, these proportions are dramatically different when the susceptibility threshold is high, e.g., 0.8, compared to the case when it is as low as 0.2. Particularly, in the first case, a practically entire increase of the infection curve for the increased transmission rate can be attributed to the infections by asymptomatic carriers. On the other hand, the situation is not symmetrical when the number of asymptomatic comprises 20% of all infected. In this case, we find that the proportions of infected by presymptomatic carriers exceed the proportion of infected by asymptomatic by an amount, which increases with the increased basic transmission rate.<fig id="fig6"><label>Fig. 6</label><caption><p>Top panel: Varied-intensity social participation activity time series <inline-formula><mml:math id="M97" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. Bottom panels: For two threshold susceptibilities <inline-formula><mml:math id="M98" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, shown in each panel, the total infection curve <inline-formula><mml:math id="M99" altimg="si33.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and the corresponding proportions of infected by asymptomatic and by presymptomatic carriers for two different values of the basic transmission rate <inline-formula><mml:math id="M100" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> = 0.23 and 0.39. The number of agents created during the simulations is 13905; the number of infected agents 10674 and viruses 802254 occurred for <inline-formula><mml:math id="M101" altimg="si44.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula>, meanwhile 10611 agents and 2679841 virus nodes appeared when <inline-formula><mml:math id="M102" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula>.</p></caption><alt-text id="alttext0040">Fig. 6</alt-text><graphic xlink:href="gr6_lrg"/></fig></p>
            </sec>
            <sec id="sec5">
              <label>5</label>
              <title>Discussion and conclusions</title>
              <p id="p0100">We have studied the microscopic dynamics modelling of SARS-CoV-2 epidemics by building on the modelling framework developed in Ref. [<xref rid="bib1" ref-type="bibr">1</xref>]. By keeping information about the host that produces a virus implicated in an infection event, we have been able to disentangle the cases attributed to asymptomatic from those caused by presymptomatic virus carriers. With the extensive simulations that comprise up to 16 weeks of the evolution time with the hourly resolution, we have demonstrated how the corresponding proportions of the infection curve vary in time and depend on the implicated bio-social factors. Dealing with a highly nonlinear stochastic process, we note that changing a parameter that affects the events at the microscopic interaction scale may lead to an altered course of events and a different final outcome. At the same time, our results revealed certain regularities regarding the groups of social and biological factors. Specifically:<list list-type="simple" id="ulist0015"><list-item id="u0025"><label>•</label><p id="p0105">The overall infection level critically depends on social participation activity. Hence, the increase of the infection curve can be forcefully controlled, e.g., by temporally reducing the social activity level, having the other factors fixed;</p></list-item><list-item id="u0030"><label>•</label><p id="p0110">For a given total infection, the relative ratio of the cases infected by asymptomatic carriers to the cases infected by presymptomatic carriers crucially depends on several biological factors. These are, the threshold susceptibility (depending on the virus pathogenicity and human genetic and other health factors of the implicated actors), and the virus transmissivity;</p></list-item><list-item id="u0035"><label>•</label><p id="p0115">The interplay between social and biological factors can be altered, increasing the proportion of cases attributed to the asymptomatic carriers, when the virus transmissivity considerably increases. For example, the considered situation where the basic transmission rate is increased by 70% is motivated by recently debated potential mutations of SARS-CoV-2, see Refs. [<xref rid="bib27" ref-type="bibr">27</xref>,<xref rid="bib28" ref-type="bibr">28</xref>].</p></list-item></list>
</p>
              <p id="p0120">In this modelling framework, we consider high-resolution temporal fluctuations of a community's cumulative social participation but without a specified spatial dimension. For different challenges of modelling COVID-19 epidemics, see the agent-based [<xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>, <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>] and compartmental dynamics models [<xref rid="bib51" ref-type="bibr">51</xref>,<xref rid="bib52" ref-type="bibr">52</xref>]. Our model focuses on the individual features of agents and viruses that impact the infection process at the elementary interaction scale, while accounting for the global-scale outcomes, and in this sense, it is unique in the current literature. The model can be adequately extended to consider the virus mutations during the entire process [<xref rid="bib1" ref-type="bibr">1</xref>]. Such mutations can lead to markedly altered pathogenicity or transmissivity, resulting in the simultaneous presence of different strains. At the agents' level, a time-dependent infectiousness profile during the agent's infectious time can be included. Moreover, individual or group's attitudes towards respecting non-medical prevention measures can be implemented at different levels, i.e., by modifying the basic transmission rate or affecting each infection event.</p>
              <p id="p0125">In conclusion, our microscopic dynamics modelling of the SARS-CoV-2 epidemics reveals the interplay between different biological and social factors of this nonlinear process, which shapes the increase of the infectious curve and the proportions attributed to asymptomatic and presymptomatic virus carriers. Given social participation activity under control, our results shed light on the intrinsic action mechanisms of the key biological factors. In particular, these are the critical threshold susceptibility to the virus and the increased virus transmissivity, which lead to the increased proportions of the infections by asymptomatic carriers. Thus, our theoretical study suggests that the role of asymptomatic and presymptomatic carriers in the SARS-CoV-2 epidemics can be revealed by assessing these biological factors. Apart from the health-related and genetic features of a given population, these factors depend on the predominant virus type and mutations. At a community level, assuming that pertinent empirical data on the virus transmissivity and pathogenicity can be available, these findings should assist in better estimates of the impact of the hidden asymptomatic carriers, and consequently, in the design of the appropriately improved measures.</p>
            </sec>
            <sec sec-type="COI-statement">
              <title>Declaration of competing interest</title>
              <p id="p0130">Authors declare no conflict of interest.</p>
            </sec>
          </body>
          <back>
            <ref-list id="cebib0010">
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <element-citation publication-type="journal" id="sref1">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tadić</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Melnik</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modeling latent infection transmissions through biosocial stochastic dynamics</article-title>
                  <source>PloS One</source>
                  <volume>15</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">e0241163</object-id>
                </element-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <element-citation publication-type="journal" id="sref2">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brauer</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mathematical epidemiology: past, present and future</article-title>
                  <source>Infectious Disease Modelling</source>
                  <volume>2</volume>
                  <year>2017</year>
                  <fpage>113</fpage>
                  <lpage>127</lpage>
                  <pub-id pub-id-type="pmid">29928732</pub-id>
                </element-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <element-citation publication-type="book" id="sref3">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schneider</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Krogan</surname>
                      <given-names>N.J.</given-names>
                    </name>
                    <name>
                      <surname>Chanda</surname>
                      <given-names>S.K.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Chapter 12 - the virus–host interactome: knowing the players to understand the game</chapter-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Katze</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Korth</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Law</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Nathanson</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <source>Viral Pathogenesis</source>
                  <edition>third ed.</edition>
                  <year>2016</year>
                  <publisher-name>Academic Press</publisher-name>
                  <publisher-loc>Boston</publisher-loc>
                  <fpage>157</fpage>
                  <lpage>167</lpage>
                </element-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <element-citation publication-type="book" id="sref4">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doms</surname>
                      <given-names>R.W.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Chapter 3 - basic concepts: a step-by-step guide to viral infection</chapter-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Katze</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Korth</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Law</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Nathanson</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <source>Viral Pathogenesis</source>
                  <edition>third ed.</edition>
                  <year>2016</year>
                  <publisher-name>Academic Press</publisher-name>
                  <publisher-loc>Boston</publisher-loc>
                  <fpage>29</fpage>
                  <lpage>40</lpage>
                </element-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <element-citation publication-type="book" id="sref5">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferris</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Heise</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Baric</surname>
                      <given-names>R.S.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Chapter 13 - host genetics: it is not just the virus, stupid</chapter-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Katze</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Korth</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Law</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Nathanson</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <source>Viral Pathogenesis</source>
                  <edition>third ed.</edition>
                  <year>2016</year>
                  <publisher-name>Academic Press</publisher-name>
                  <publisher-loc>Boston</publisher-loc>
                  <fpage>169</fpage>
                  <lpage>179</lpage>
                </element-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <element-citation publication-type="journal" id="sref6">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cevik</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kuppalli</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kindrachuk</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Peiris</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Virology, transmissions, and pathogenesis of sars-cov-2</article-title>
                  <source>BMJ</source>
                  <volume>371</volume>
                  <year>2020</year>
                  <fpage>m3862</fpage>
                  <pub-id pub-id-type="pmid">33097561</pub-id>
                </element-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <element-citation publication-type="journal" id="sref7">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dufloo</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grzelak</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Staropoli</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies</article-title>
                  <source>medRxiv</source>
                  <year>2020</year>
                  <pub-id pub-id-type="doi">10.1101/2020.11.12.20230508v1</pub-id>
                </element-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <element-citation publication-type="journal" id="sref8">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiong</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Invisible spread of sars-cov-2</article-title>
                  <source>Lancet Infect. Dis.</source>
                  <volume>20</volume>
                  <year>2020</year>
                  <fpage>1011</fpage>
                  <lpage>1012</lpage>
                </element-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <mixed-citation publication-type="other" id="sref9">C.E. Enyoh, A.W. Verla, W. Qingyue, D.K. Yadav, M.A. Hossain Chowdhury, B.O. Isiuku, T. Chowdhury, F.C. Ibe, E.N. Verla, T.O. Maduka, Indirect Exposure to Novel Coronavirus (Sars-cov-2): an Overview of Current Knowledge, preprints.org, art.2020040460, doi: 10.20944/preprints202004.0460.v1.</mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <element-citation publication-type="journal" id="sref10">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cai</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gamber</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Indirect virus transmission in cluster of covid-19 cases, Wenzhou, China</article-title>
                  <source>Emerg. Infect. Dis.</source>
                  <volume>26</volume>
                  <year>2020</year>
                  <fpage>1343</fpage>
                  <lpage>1345</lpage>
                  <comment>2020</comment>
                  <pub-id pub-id-type="pmid">32163030</pub-id>
                </element-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <element-citation publication-type="journal" id="sref11">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pathogenicity and transmissibility of 2019-nCoV–a quick overview and comparison with other emerging viruses</article-title>
                  <source>Microb. Infect.</source>
                  <volume>22</volume>
                  <year>2020</year>
                  <fpage>69</fpage>
                  <lpage>71</lpage>
                </element-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <element-citation publication-type="journal" id="sref12">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cevik</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Tate</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lloyd</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Maraolo</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Schafers</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ho</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis</article-title>
                  <source>The Lancet Microbe</source>
                  <volume>2</volume>
                  <year>2021</year>
                  <fpage>e13</fpage>
                  <lpage>e22</lpage>
                  <pub-id pub-id-type="pmid">33521734</pub-id>
                </element-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <element-citation publication-type="journal" id="sref13">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Initial whole-genome sequencing and analysis of the host genetic contribution to covid-19 severity and susceptibility</article-title>
                  <source>Cell Discovery</source>
                  <volume>6</volume>
                  <year>2020</year>
                  <fpage>83</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41421-020-00231-4</pub-id>
                  <pub-id pub-id-type="pmid">33298875</pub-id>
                </element-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <element-citation publication-type="journal" id="sref14">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (covid-19) implicate special control measures</article-title>
                  <source>J. Med. Virol.</source>
                  <volume>92</volume>
                  <year>2020</year>
                  <fpage>568</fpage>
                  <lpage>576</lpage>
                  <pub-id pub-id-type="pmid">32134116</pub-id>
                </element-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <element-citation publication-type="journal" id="sref15">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nersisyan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Engibaryan</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Gorbonos</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kirdey</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Makhonin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Tonevitsky</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The potential role of miRNAs-21-3p in coronavirus-host interplay</article-title>
                  <source>PeerJ</source>
                  <volume>8</volume>
                  <year>2020</year>
                  <fpage>e994</fpage>
                </element-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <element-citation publication-type="journal" id="sref16">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Geng</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>New understanding of the damage of sars-cov-2 infection outside the respiratory system</article-title>
                  <source>Biomed. Pharmacother.</source>
                  <volume>127</volume>
                  <year>2020</year>
                  <fpage>110195</fpage>
                  <pub-id pub-id-type="pmid">32361161</pub-id>
                </element-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <element-citation publication-type="journal" id="sref17">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chin</surname>
                      <given-names>A.W.H.</given-names>
                    </name>
                    <name>
                      <surname>Chu</surname>
                      <given-names>J.T.S.</given-names>
                    </name>
                    <name>
                      <surname>Perera</surname>
                      <given-names>M.R.A.</given-names>
                    </name>
                    <name>
                      <surname>Hui</surname>
                      <given-names>K.P.Y.</given-names>
                    </name>
                    <name>
                      <surname>Yen</surname>
                      <given-names>H.-L.</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>M.C.W.</given-names>
                    </name>
                    <name>
                      <surname>Peiris</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Poon</surname>
                      <given-names>L.L.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Stability of sars-cov-2 in different environmental conditions</article-title>
                  <source>Lancet Microbe</source>
                  <volume>1</volume>
                  <year>2020</year>
                  <fpage>e10</fpage>
                  <pub-id pub-id-type="pmid">32835322</pub-id>
                </element-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <element-citation publication-type="journal" id="sref18">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meyers</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Goetz</surname>
                      <given-names>I.A.</given-names>
                    </name>
                    <name>
                      <surname>Botros</surname>
                      <given-names>F.T.</given-names>
                    </name>
                    <name>
                      <surname>Knorr</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Manner</surname>
                      <given-names>D.H.</given-names>
                    </name>
                    <name>
                      <surname>Woodward</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>A cross-sectional community-based observational study of asymptomatic sars-cov-2 prevalence in the greater indianapolis area</article-title>
                  <source>J. Med. Virol.</source>
                  <volume>92</volume>
                  <year>2020</year>
                  <fpage>2874</fpage>
                  <lpage>2879</lpage>
                  <pub-id pub-id-type="pmid">32543722</pub-id>
                </element-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <element-citation publication-type="journal" id="sref19">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meyerowitz</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Richterman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bogoch</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Low</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Cevik</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Towards an accurate and systematic characterization of persistently asymptomatic infection with sars-cov-2</article-title>
                  <source>Lancet Infect. Dis.</source>
                  <year>2020</year>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30837-9</pub-id>
                </element-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <element-citation publication-type="journal" id="sref20">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yanes-Lane</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Winters</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Fregonese</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Bastos</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Perlman-Arrow</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Menzies</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis</article-title>
                  <source>PloS One</source>
                  <volume>15</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">e0241536</object-id>
                </element-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <element-citation publication-type="journal" id="sref21">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buitrago-Garcia</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Egli-Gany</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Counotte</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Hossmann</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Imeri</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Ipekci</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Salanti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Low</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Occurrence and transmission potential of asymptomatic and presymptomatic sars-cov-2 infections: a living systematic review and meta-analysis</article-title>
                  <source>PLoS Med.</source>
                  <volume>17</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">e1003346</object-id>
                </element-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <element-citation publication-type="journal" id="sref22">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Polán</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Perez-Gomez</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Pastor-Barriuso</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Oteo</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hernan</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Perez-Olmeda</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study</article-title>
                  <source>Lancet</source>
                  <volume>396</volume>
                  <year>2020</year>
                  <fpage>535</fpage>
                  <lpage>544</lpage>
                  <pub-id pub-id-type="pmid">32645347</pub-id>
                </element-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <element-citation publication-type="journal" id="sref23">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ye</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Rong</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Delivery of infection from asymtomatic carriers of COVID-19 in familial cluster</article-title>
                  <source>Int. J. Infect. Dis.</source>
                  <volume>94</volume>
                  <year>2020</year>
                  <fpage>133</fpage>
                  <lpage>138</lpage>
                  <pub-id pub-id-type="pmid">32247826</pub-id>
                </element-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <element-citation publication-type="journal" id="sref24">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arons</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Hatfield</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Readdy</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Kimball</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>James</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>J.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility</article-title>
                  <source>N. Engl. J. Med.</source>
                  <volume>382</volume>
                  <year>2020</year>
                  <fpage>2081</fpage>
                  <lpage>2090</lpage>
                  <pub-id pub-id-type="pmid">32329971</pub-id>
                </element-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <element-citation publication-type="journal" id="sref25">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moghadas</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Fitzpatrick</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Sah</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Pandey</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Shoukat</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Singer</surname>
                      <given-names>B.H.</given-names>
                    </name>
                    <name>
                      <surname>Galvani</surname>
                      <given-names>A.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>The implications of silent transmission for the control of COVID-19 outbreaks</article-title>
                  <source>Proc. Natl. Acad. Sci. Unit. States Am.</source>
                  <volume>117</volume>
                  <year>2020</year>
                  <fpage>17513</fpage>
                  <lpage>17515</lpage>
                </element-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <element-citation publication-type="journal" id="sref26">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Peirlinck</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Linka</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Costabal</surname>
                      <given-names>F.S.</given-names>
                    </name>
                    <name>
                      <surname>Bhattacharya</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bendavid</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Ioannidis</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Kuhl</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Visualizing the invisible: the effect of asymptomatic transmission on the outbreak dynamics of COVID-19</article-title>
                  <source>Comput. Methods Appl. Mech. Eng.</source>
                  <volume>372</volume>
                  <year>2020</year>
                  <fpage>113410</fpage>
                  <pub-id pub-id-type="pmid">33518823</pub-id>
                </element-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <element-citation publication-type="journal" id="sref27">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Dorp</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Richard</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>C.C.S.</given-names>
                    </name>
                    <name>
                      <surname>Shaw</surname>
                      <given-names>L.P.</given-names>
                    </name>
                    <name>
                      <surname>Acman</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ballox</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>No evidence for increased transmissibility from recurrent mutations in sars-cov-2</article-title>
                  <source>Nat. Commun.</source>
                  <volume>11</volume>
                  <year>2020</year>
                  <fpage>5986</fpage>
                  <pub-id pub-id-type="pmid">33239633</pub-id>
                </element-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <element-citation publication-type="journal" id="sref28">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Callawey</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Making sense of coronavirus mutations</article-title>
                  <source>Nature</source>
                  <volume>585</volume>
                  <year>2020</year>
                  <fpage>174</fpage>
                  <lpage>177</lpage>
                  <pub-id pub-id-type="pmid">32901123</pub-id>
                </element-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <element-citation publication-type="book" id="sref29">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gam</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pandurangan</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Gough</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Genetic Risk Factors for Death with Sars-Cov-2 from the UK Biobank</chapter-title>
                  <year>2020</year>
                  <publisher-name>medRxiv</publisher-name>
                  <comment>art.2020.07.01.20144592</comment>
                </element-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <element-citation publication-type="journal" id="sref30">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Selvan</surname>
                      <given-names>M.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk factors for death from covid-19</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <volume>20</volume>
                  <year>2020</year>
                  <fpage>407</fpage>
                </element-citation>
              </ref>
              <ref id="bib31">
                <label>31</label>
                <element-citation publication-type="journal" id="sref31">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singanayagam</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Charlett</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lopez Bernal</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Saliba</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020</article-title>
                  <source>Euro Surveill.</source>
                  <volume>25</volume>
                  <issue>2020</issue>
                  <year>2020</year>
                  <fpage>2001483</fpage>
                </element-citation>
              </ref>
              <ref id="bib32">
                <label>32</label>
                <element-citation publication-type="journal" id="sref32">
                  <person-group person-group-type="author">
                    <name>
                      <surname>He</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>E.H.Y.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Temporal dynamics in viral shedding and transmissibility of covid-19</article-title>
                  <source>Nat. Med.</source>
                  <volume>26</volume>
                  <year>2020</year>
                  <fpage>672</fpage>
                  <lpage>675</lpage>
                  <pub-id pub-id-type="pmid">32296168</pub-id>
                </element-citation>
              </ref>
              <ref id="bib33">
                <label>33</label>
                <element-citation publication-type="journal" id="sref33">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Slifka</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Is presymptomatic spread a major contributor to COVID-19 transmission?</article-title>
                  <source>Nat. Med.</source>
                  <volume>26</volume>
                  <year>2020</year>
                  <fpage>1531</fpage>
                  <lpage>1533</lpage>
                  <pub-id pub-id-type="pmid">32807936</pub-id>
                </element-citation>
              </ref>
              <ref id="bib34">
                <label>34</label>
                <element-citation publication-type="journal" id="sref34">
                  <person-group person-group-type="author">
                    <name>
                      <surname>To</surname>
                      <given-names>K.K.-W.</given-names>
                    </name>
                    <name>
                      <surname>Tsang</surname>
                      <given-names>O.T.-Y.</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>W.-S.</given-names>
                    </name>
                    <name>
                      <surname>Tam</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>T.-C.</given-names>
                    </name>
                    <name>
                      <surname>Lung</surname>
                      <given-names>D.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by sars-cov-2: an observational cohort study</article-title>
                  <source>Lancet Infect. Dis.</source>
                  <volume>20</volume>
                  <year>2020</year>
                  <fpage>565</fpage>
                  <lpage>574</lpage>
                  <pub-id pub-id-type="pmid">32213337</pub-id>
                </element-citation>
              </ref>
              <ref id="bib35">
                <label>35</label>
                <element-citation publication-type="journal" id="sref35">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anastassopoulou</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Russo</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Tsakris</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Siettos</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Data-based analysis, modelling and forecasting of the covid-19 outbreak</article-title>
                  <source>PloS One</source>
                  <volume>15</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">e0230405</object-id>
                </element-citation>
              </ref>
              <ref id="bib36">
                <label>36</label>
                <element-citation publication-type="book" id="sref36">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Magal</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Webb</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Predicting the Number of Reported and Unreported Cases for the Covid-19 Epidemic in South Korea</chapter-title>
                  <year>2020</year>
                  <publisher-name>medRxiv</publisher-name>
                  <publisher-loc>italy, France and Germany</publisher-loc>
                  <fpage>2020</fpage>
                  <comment>03.21.20040154</comment>
                </element-citation>
              </ref>
              <ref id="bib37">
                <label>37</label>
                <element-citation publication-type="journal" id="sref37">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qiu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Nergiz</surname>
                      <given-names>A.I.</given-names>
                    </name>
                    <name>
                      <surname>Maraolo</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Bogoch</surname>
                      <given-names>I.I.</given-names>
                    </name>
                    <name>
                      <surname>Low</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Cevik</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Defining the role of asymptomatic and pre-symptomatic sars-cov-2 transmission – a living systematic review</article-title>
                  <source>medRxiv</source>
                  <year>2020</year>
                  <fpage>2020</fpage>
                  <comment>09.01.20135194v2</comment>
                </element-citation>
              </ref>
              <ref id="bib38">
                <label>38</label>
                <element-citation publication-type="journal" id="sref38">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yanes-Lane</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Winters</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Fregonese</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Bastos</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Perlman-Arrow</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Menzies</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proportion of asymptomatic infection among covid-19 positive persons and their transmission potential: a systematic review and meta-analysis</article-title>
                  <source>PloS One</source>
                  <volume>15</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">e0241536</object-id>
                </element-citation>
              </ref>
              <ref id="bib39">
                <label>39</label>
                <element-citation publication-type="journal" id="sref39">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19 transmission through asymptomatic carriers is a challenge to containment</article-title>
                  <source>Influenza and other respiratory viruses</source>
                  <volume>14</volume>
                  <year>2020</year>
                  <fpage>474</fpage>
                  <lpage>475</lpage>
                  <pub-id pub-id-type="pmid">32246886</pub-id>
                </element-citation>
              </ref>
              <ref id="bib40">
                <label>40</label>
                <element-citation publication-type="journal" id="sref40">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giordano</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Blanchini</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Bruno</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Colaneri</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Di Filippo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Di Matteo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Colaneri</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modelling the covid-19 epidemic and implementation of population-wide interventions in Italy</article-title>
                  <source>Nat. Med.</source>
                  <volume>26</volume>
                  <year>2020</year>
                  <fpage>855</fpage>
                  <lpage>860</lpage>
                  <pub-id pub-id-type="pmid">32322102</pub-id>
                </element-citation>
              </ref>
              <ref id="bib41">
                <label>41</label>
                <element-citation publication-type="journal" id="sref41">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kucharski</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>T.W.</given-names>
                    </name>
                    <name>
                      <surname>Diamond</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Edmunds</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Funk</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Early dynamics of transmission and control of covid-19: a mathematical modelling study</article-title>
                  <source>Lancet Infect. Dis.</source>
                  <volume>20</volume>
                  <year>2020</year>
                  <fpage>553</fpage>
                  <lpage>558</lpage>
                  <pub-id pub-id-type="pmid">32171059</pub-id>
                </element-citation>
              </ref>
              <ref id="bib42">
                <label>42</label>
                <element-citation publication-type="journal" id="sref42">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cuevas</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>An agent-based model to evaluate the covid-19 transmission risks in facilities</article-title>
                  <source>Comput. Biol. Med.</source>
                  <volume>121</volume>
                  <year>2020</year>
                  <fpage>103827</fpage>
                  <pub-id pub-id-type="pmid">32568667</pub-id>
                </element-citation>
              </ref>
              <ref id="bib43">
                <label>43</label>
                <element-citation publication-type="journal" id="sref43">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wolfram</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>An agent-based model of covid-19</article-title>
                  <source>Complex Syst.</source>
                  <volume>29</volume>
                  <year>2020</year>
                  <fpage>87</fpage>
                  <lpage>105</lpage>
                </element-citation>
              </ref>
              <ref id="bib44">
                <label>44</label>
                <element-citation publication-type="book" id="sref44">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Müller</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Balmer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Charlton</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Ewert</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Neumann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Rakow</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schlenther</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Nagel</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>A Realistic Agent-Based Simulation Model for COVID-19 Based on a Traffic Simulation and Mobile Phone Data</chapter-title>
                  <comment>arXiv</comment>
                  <year>2020</year>
                  <fpage>11453v1</fpage>
                  <comment>2011</comment>
                </element-citation>
              </ref>
              <ref id="bib45">
                <label>45</label>
                <element-citation publication-type="journal" id="sref45">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burda</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modelling excess mortality in covid-19-like epidemics</article-title>
                  <source>Entropy</source>
                  <volume>22</volume>
                  <year>2020</year>
                  <fpage>e1236</fpage>
                  <pub-id pub-id-type="pmid">33287004</pub-id>
                </element-citation>
              </ref>
              <ref id="bib46">
                <label>46</label>
                <mixed-citation publication-type="other" id="sref46">S.L. Chang, N. Harding, C. Zacherson, O.M. Cliff, M. Prokopenko, Modelling transmission and control of the covid-19 pandemic in Australia, Nat. Commun., 11 (20200 5710.</mixed-citation>
              </ref>
              <ref id="bib47">
                <label>47</label>
                <element-citation publication-type="journal" id="sref47">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kerr</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Stuart</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Mistry</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Abeysuriya</surname>
                      <given-names>R.G.</given-names>
                    </name>
                    <name>
                      <surname>Hart</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Rosenfeld</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Covasim: an agent-based model of COVID-19 dynamics and interventions</article-title>
                  <source>medRxiv</source>
                  <year>2020</year>
                  <fpage>2020</fpage>
                  <comment>05.10.20097469</comment>
                </element-citation>
              </ref>
              <ref id="bib48">
                <label>48</label>
                <element-citation publication-type="journal" id="sref48">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Šuvakov</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mitrović</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gligorijević</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Tadić</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>How the online social networks are used: dialogues-based structure of myspace</article-title>
                  <source>J. R. Soc. Interface</source>
                  <volume>10</volume>
                  <year>2012</year>
                  <fpage>20120819</fpage>
                </element-citation>
              </ref>
              <ref id="bib49">
                <label>49</label>
                <element-citation publication-type="book" id="sref49">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gonzales</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hernando</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Unraveling the Interplay of the Urban Form, Mobility and Social Mixing in the Light of the Covid-19 Pandemic, Book of Abstracts, Conference on Complex Systems CCS2020-Online</chapter-title>
                  <year>2020</year>
                  <fpage>138</fpage>
                </element-citation>
              </ref>
              <ref id="bib50">
                <label>50</label>
                <element-citation publication-type="book" id="sref50">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gam</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pandurangan</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Gough</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Genetic Risk Factors for Death with Sars-Cov-2 from the UK Biobank. medRxiv</chapter-title>
                  <year>2020</year>
                  <fpage>2020</fpage>
                  <comment>07.01.20144592</comment>
                </element-citation>
              </ref>
              <ref id="bib51">
                <label>51</label>
                <element-citation publication-type="journal" id="sref51">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arenas</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Cota</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Gómes-Gardeñes</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gómes</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Granell</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Matamalas</surname>
                      <given-names>J.T.</given-names>
                    </name>
                    <name>
                      <surname>Soriano-Panos</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Steingger</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modeling the spatiotemporal epidemics spreading of COVID-19 and the impact of mobility and social distancing interventions</article-title>
                  <source>Phys. Rev. X</source>
                  <volume>10</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">041055</object-id>
                </element-citation>
              </ref>
              <ref id="bib52">
                <label>52</label>
                <element-citation publication-type="journal" id="sref52">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bertozzi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Franco</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Mohler</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Short</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Sledge</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The challenges of modeling and forcasting the spread of COVID-19</article-title>
                  <source>Proc. Natl. Acad. Sci. Unit. States Am.</source>
                  <volume>117</volume>
                  <year>2020</year>
                  <fpage>16732</fpage>
                  <lpage>16738</lpage>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="appsec1">
              <label>Appendix</label>
              <title>Program flow</title>
              <p id="p0140">
                <fig id="undfig1" position="anchor">
                  <alt-text id="alttext0010">Image 1</alt-text>
                  <graphic xlink:href="fx1_lrg"/>
                </fig>
              </p>
            </sec>
            <ack id="ack0010">
              <title>Acknowledgments</title>
              <p id="p0135">B.T. acknowledges the financial support from the <funding-source id="gs1">Slovenian Research Agency</funding-source> (research code funding number P1-0044). R.M. thanks to the NSERC and the CRC Program for their support and he is also acknowledging the support of the BERC 2018–2021 program and <funding-source id="gs3">Spanish Ministry of Science, Innovation, and Universities</funding-source> through the Agencia Estatal de Investigacion (AEI) BCAM Severo Ochoa excellence accreditation SEV-2017-0718, and the <funding-source id="gs2">Basque Government</funding-source> fund “AI in BCAM EXP. 2019/00432”.</p>
            </ack>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
